Fact CheckerSign in

NCT05785598Completed

Super-resolution Clinical Brain Ultrasound

Study of Perforating Arteries Detection by Ultrasound Localization Microscopy (ULM) With a Commercial Conventional Ultrasound Scanner

Source: ClinicalTrials.gov · Last updated 24 Apr 2026

Brief summary (registry, in English)

Transcranial Doppler ultrasonography with injection of contrast agent (intravenously to enhance the ultrasound signal) is a non-invasive technique that has been used for years to study intracranial vessels that constitute the polygon of Willis. However, this technique does not allow good visualization of small vessels, such as perforating arteries. Ultrasound localization microscopy (ULM) is based on the principle of localizing injected microbubbles in order to follow their movement to map the microvascular structure. The concentration of these microbubbles must remain low (in contrast to its classical use in Doppler ultrasound) in order to isolate and localize them. By using the same images as those performed in clinical routine by Doppler ultrasound and by processing the data offline, ULM would increase the resolution by a factor of 10 allowing potential observation of perforating arteries.

Status (registry)
Completed
Study type
Observational
Enrollment
24 (actual)
First submitted
14 Mar 2023
Start date
30 Mar 2023
Primary completion date
30 Mar 2024
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
Stroke
NCT number
NCT05785598

What you commit to

  • Study type: Observational
  • Participants enrolled: 24
  • From 30 Mar 2023 to the primary completion date, 30 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient not affiliated to French Social Security.
  • Patient under guardianship or curatorship.
  • Pregnant or breastfeeding patients

Who the study is looking for

  • Patients with ischemic stroke hospitalized in the neurology department of the Bichat Hospital in the absence of middle cerebral artery occlusion or lacunar disease.
    • or
  • Patients followed in the neurology department of the Bichat/Lariboisière hospital with a diagnosis of Moya-Moya disease or syndrome
  • Patient who has had a TST with contrast injection as part of his follow-up
  • Patient who has had an MRI as part of his follow-up
  • Presence of a temporal window that allows ultrasound insonification of the polygon circle of Willis.
  • Age over 18 years.
  • Patient not objecting to the analysis of their data

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AP-HP, Bichat Hospital
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.